CML-227: Pilot Study on a Response-Directed Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Myeloid Leukemia.
| Autor: | Dalle, Iman Abou, Ibrahim, Ali, MahfouzDepartment of Pathology and Laboratory Medicine,American University of Beirut Medical Center, Beirut, Lebanon, Rami, Cheikh, Jean El, Bazarbachi, Ali |
|---|---|
| Zdroj: | Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS330-S331, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect